Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule BLX-7006 reduced the weight of obese mice by 15% over a 28-day span.
“We are thrilled with the positive outcomes from our preclinical studies,” Biolexis chief scientific officer Hariprasad Vankayalapati,…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
SocialClimb Partners with Arbor Associates to Revolutionize CAHPS Survey Submission and Reporting
LEHI, Utah, Oct. 2, 2023 /PRNewswire/ — SocialClimb, the leading platform in healthcare marketing, is thrilled to announce its strategic partnership with Arbor Associates, specialists in government-mandated data analysis and survey management. This collaboration uniquely […]
CenExel Clinical Research Network Expands Capabilities Across Sites Nationwide
DRAPER, Utah, March 3, 2026 /PRNewswire/ — CenExel, a leading, wholly owned clinical research site network, announced a series of strategic expansions across its Tampa, Denver, Anaheim, Toms River and Atlanta sites, significantly enhancing its […]
Senators question how HHS plans to roll out new drug pricing reforms
While CMS drug price negotiations won’t actually kick off until 2026, a group of more than two dozen Republican senators is already raising questions about how this new law will be implemented. The partisan law […]
